Medical Park Seyhan Hastanesi

Mersin 33200

0 studies enrolling now · 2 studies all time

What they study most

Extensive-Stage Small-Cell Lung Cancer, Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer, Small-Cell Lung Cancer

Studies at this site

• Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) — Running, not enrolling
• Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab — Running, not enrolling